-
2023-508398-10-00
6
2024-12-12
ANCA-associated vasculitis
-
2024-518857-41-00
6
2024-11-29
HPV infection and related diseases, such as cervical intraepithelial n
-
2023-509994-22-00
5
2024-11-15
cutaneous malignant melanoma
-
2024-517611-67-00
4
2024-11-01
papillary craniopharyngioma
-
2024-511319-91-00
5
2024-10-23
Advanced non-small cell lung cancer with HER2 (ERBB2) mutation
-
2022-501892-14-00
5
2024-10-14
Prostate cancer
-
2022-502776-22-00
5
2024-09-05
Anemia
-
2023-507407-59-00
5
2024-07-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-508156-20-00
5
2024-06-10
Uveal Melanoma Liver Metastases
-
2023-507385-11-00
10
2024-05-06
-Hereditary Transthyretin Amyloidosis with Polyneuropathy (ATTRv-PN)
-
-
2023-505375-75-00
5
2024-04-04
Onset of Atrial Fibrillation and Acute Kidney Injury after coronary ar
-
2023-507441-29-00
5
2024-02-29
Pneumonia
-
2022-500570-33-00
5
2024-02-28
Prostate cancer
-
2022-502707-29-00
5
2024-02-07
Preeclampsia
-
2023-509142-35-00
6
2024-01-29
Atrial fibrillation after stress (e.g., noncardiac surgery or acute me
-
2023-503935-16-00
4
2023-12-15
Ectopic pregnancy
-
2023-503582-35-00
6
2023-10-26
Staphylococcus aureus bacteremia
-
2023-504999-25-00
5
2023-07-14
Acute Myeloid Leukemia
-
2022-501504-95-00
4
2023-06-23
Non-metastatic HER2-positive Breast Cancer
-
2022-501600-10-00
5
2023-02-07
Atrial fibrillation and Chronic Kidney Disease stage 5
-
2022-501180-40-00
5
2022-06-17
Ewing Sarcoma
-
2024-518172-31-01
5
2022-06-14
EGFR-mutated non-small cell lung cancer (NSCLC) not amenable for curat
-
2024-511201-32-00
5
2022-06-13
Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
-
2023-503843-33-00
5
2022-05-04
Coronary Artery Disease